LEO 90100 clinical trials
How each study uses LEO 90100 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
10 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Betamethasone dipropionate, calcipotriol drug combination (1) · Betamethasone dipropionate (1) · Betamethasone (1) · Mometasone Furoate (1) · Hydrocortisone butyrate (1)
Studies
Open first, then newest update. How each study uses LEO 90100 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT02310646Written as LEO 90100 Aerosol FoamHow we know
- A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis VulgarisCompletedPhase 2LEO PharmaNCT02518048Written as LEO 90100 Aerosol foamHow we know
- LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT02132936Written as LEO 90100 aerosol foamHow we know
- Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT03806790Written as LEO 90100 foamHow we know
- A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis VulgarisCompletedPhase 2LEO PharmaNCT01347255Written as LEO90100 cutaneous spray, ointmentHow we know
- Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese SubjectsCompletedPhase 1LEO PharmaNCT03442244Written as LEO 90100 foamHow we know
- A Vasoconstriction Study With LEO 90100CompletedPhase 1LEO PharmaNCT01946386Written as LEO 90100 Aerosol, foamHow we know
- Dermatopharmacokinetic Trial of LEO 90100 FoamCompletedPhase 1LEO PharmaNCT03476746Written as LEO 90100 foamHow we know
- LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT02899962Written as LEO 90100 aerosol foamHow we know
- Vasoconstriction Trial With LEO 90100 Aerosol FoamCompletedPhase 1LEO PharmaNCT02973776Written as LEO 90100 aerosol foamHow we know